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Special Susceptibility of the Child to Certain
Radiation-induced Cancers
RobertW. Miller
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The carcinogenic effects of exposure to ionizing radiation vary markedly with age, as revealed by studies of Japanese atomic bomb survivors and of
Marshall Islanders exposed to fallout from U.S. nuclear weapons tests in the South Pacific in 1954. An increase in cancers of adulthood after
intrauterine exposure, as reported in 1988, has not been sustained. After childhood exposure, increases in leukemia, breast cancer, and thyroid cancer
are well established. The carcinogenic effects of radiation on the young have been reported after intrauterine exposures and after exposures during
childhood. Cancers with short latent periods such as leukemia occur during childhood, but those with long latent periods such as breast cancer
occur in adulthood. - Environ Health Perspect 103(Suppl 6):41-44 (1995)
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Intrauterine Exposures
Since 1956, Stewart and her associates (1)
have published observations on cancer dur-
ing childhood after a maternal history of
exposure to diagnostic radiation during
pregnancy [for example, Bithell and
Stewart (2)]. Initially their observations
were confirmed by a more objective study
of obstetric records in New England by
MacMahon (3). Extension ofhis findings,
both geographically and in time, still
showed a 1.5-fold excess of childhood
leukemia, but no longer showed any
increase in the relative risk of other child-
hood cancers (4). Other studies also failed
to show any increase, notably among the
Japanese atomic bomb survivors exposed
in utero (5). In 1985, in an editorial in the
New EnglandJournal ofMedicine (6),
MacMahon wrote, "It seems likely that the
question of the association between fetal
irradiation and childhood cancer will fade
into medical history unresolved and
remain a source of more confusion than
enlightenment."
An excess of cancer among the Japanese
exposed in utero has been reported in a
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study through 38 years ofage (until 1984)
(7). The cancers are listed in Table 1, and a
dose-response effect is shown in Figure 1.
The authors concluded that further follow-
up is needed, but the results to date suggest
"that susceptibility to radiation-induced
cancers is higher in pre- than in postnatally
exposed . . . adults." It should be noted,
however, that the cancers in the several dose
categories show no greater frequency of
types known to be induced by radiation in
the heavily exposed as compared with the
lightly exposed or nonexposed. Ofthe six
cancers observed at 0.30+ Gy (gray, unit of
absorbed dose ofionizing radiation), three
are not known to be induced by radiation
exposure: histiocytosis, liver cancer, and
Wilms' tumor. Ofthe seven cancers in the
0.01 to 0.29 Gy dose category, only
choriocarcinoma has not been linked to
radiation exposure. In this group, there is
as yet no breast cancer, the solid tumor
most easily induced by radiation. In the
nonexposed, three of the five cancers were
breast cancers and the other two were uter-
ine cancer, which has not been related to
radiation exposure. The group with inter-
mediate exposures (0.01-0.29 Gy) had the
highest proportion ofcancers known to be
radiogenic. From this perspective, the dis-
tribution ofdiagnoses by exposure category
does not yet reveal a dose-response effect.
Table 1. Cancer among Japanese exposed in uteroto the atomic bomb.d
b Age Age at
Dose Cancer in utero, weeks onset, year Radiogenicc % Radiogenic
2.13 Ovary 36 22 +
1.39 Liver 8 6
0.90 Stomach 17 29 + 3/6 50%
0.58 Histiocytosis 36 35
0.56 Wilms' tumor 15 14
0.40 Thyroid 22 34 +
0.21 Stomach 3 24 +
0.08 Colon 7 21d +
0.04 Leukemia 4 29 +
0.02 Leukemia 38 18 + 6/7=86%
0.01 Choriocarcinoma 36 34
0.01 Bladder 23 22 +
0.01 Stomach 32 35 +
0 Breast 34 29 +
0 Breast 26 38 +
0 Breast 3 32 + 3/5 = 60%
0 Uterus 17 34
0 Uterus 8 34d
aFrom Yoshimoto et al. (7). bDose is measured in gray(Gy), a unit of absorbed dose of ionizing radiation. CKnown
d to be inducible by ionizing radiation. Age at death.
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Figure 1. Cumulative hazard rate for cancer among
survivors of intrauterine radiation in Hiroshima and
Nagasaki through 1984 for three exposure groups.
From Yoshimoto et al. (7).
In the 5 years that have passed since
Yoshimoto et al. (7) published their
report, the excess has not been sustained
(8). The fetus should be susceptible to
radiation carcinogenesis, and an excess of
radiogenic cancers may well occur in the
next few years as cancer rates rise with fur-
ther aging. It is difficult to see, however,
why exposure to ionizing radiation late in
gestation should be more carcinogenic than
exposure in early childhood.
Childhood Exposures
Leukemia
The relationship ofleukemia occurrence to
age of exposure to ionizing radiation has
been well demonstrated (Figure 2) (5).
Among survivors exposed at under 15 years
ofage, the peak occurred 5 years after expo-
sure and was sharp. The leukemogenic
effect disappeared at about 23 years after
exposure. In successively older cohorts, the
effect occurred later and the peak flattened.
The distribution of cases by cell type,
from 1950 to 1978, is shown in Table 2.
Although the numbers are small, it can be
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Figure 2. Diagram of the leukemia frequency among
atomic bomb survivors by age at exposure, latent
period, and city (Hiroshima, black; Nagasaki hatched).
ATB, attime of bomb. From lchimaru et al. (5).
Table 2. Annual incidence rates per 100,000 of
leukemia by cell type among survivors who received
1 Gy or more, by age at exposure.
Age atthe time ofthe bomb
<15 15-29 30-44 45+
Person-years 41,326 54,559 32,205 19,011
Annual incidence rates (n)
14.5 (6) 7.3(4)
2.5 (1) 12.8(7)
12.1 (5) 9.2(5)
12.1 (5) 9.2 (5)
15.5 (5)
27.9(9)
6.2 (2)
6.2 (2)
5.3(1)
36.8 (7)
5.3(1)
5.3(1)
Abbreviations: CML, chronic myelogenous leukemia;
AML, acute myelogenous leukemia; ALL, acute lym-
phocytic leukemia; AL, acute leukemia, not otherwise
specified or of othertypes. "From Ichimaru et al. (5).
seen that chronic myelogenous leukemia
(CML) occurred in children, among whom
it is usually rare, as well as among adults.
Acute myelogenous leukemia (AML) was
rare when exposure was under age 15 at the
time of the bomb (ATB); acute lympho-
cytic leukemia (ALL) was rare among those
who were over 30 years old ATB. Thus, the
type ofleukemia induced by radiation was
related to age at exposure, and, except for
CML, followed the distribution of
leukemia by cell type in nonirradiated pop-
ulations. A more accurate evaluation has
been made through a reanalysis ofleukemia
cases through 1980 using the
French-American-British classification
method and the most recent revision in
dosimetry (DS-86), but the interpretation
of the age effect on cell type has not
changed (9).
Breast Cancer
Among atomic bomb survivors exposed to
1+ Gy, age ATB has been found to be a
strong influence on the risk ofbreast cancer
(10) (Figure 3). Risk was greatest among
those under 15 years ATB and fell there-
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Figure 3. Relative risk of breast cancer by age at expo-
sure to 1 or more Gy. From Tokunaga et al. ( 10).
*Minimum feasible value for lower limit. ATB, age at
the time ofthe bomb.
after until 39 years of age. Only a small
increase occurred after age 40. The latent
period was at least 10 years, and the
increase did not occur before age 30, i.e.,
the usual age for developing breast cancer.
By contrast, the risk ofleukemia increases
within a few years after exposure regardless
ofage ATB.
Thyroid Cancer
Studies ofhuman populations exposed to
radioisotopes ofiodine have not shown an
increase in the frequency ofthyroid cancer
except in the Marshall Islands. There, the
population was exposed to both internal
and external irradiation fallout from a
nuclear weapons test in 1954. The internal
dose was mostly from short-lived I 133 and
1 135, and only about 10 to 20% came
from I 131 (11). Exposures elsewhere, as at
Chernobyl, were originally thought to be
mainly due to I 131, which, at its lower
dose rate, is far less damaging. An unpub-
lished report of about 200 cases of child-
hood thyroid cancer in Belarus since the
accident may signal that other radioiodines
were involved.
The heaviest exposure to I 131 was in
the Marshall Islands in 1954, where fallout
from a nuclear weapons test occurred.
Sixty-four people on the island of
Rongelap received 10 to 50 Gy to the thy-
roid from radioiodines, plus 1.9 Gy whole-
body exposure from external radiation.
The 18 people on Ailingnae received up to
13 Gy to the thyroid, plus 1.1 Gy ofexter-
nal radiation. On Uterik 159 people
received up to 6.7 Gy to the thyroid and
0.1 1 Gy from external radiation (11,12).
These doses were far greater than those in
Ukraine and Belarus.
Two of the nine children exposed on
Rongelap at 1 year ofage, when the thyroid
was small and its activity was great, devel-
oped myxedema and short stature (Table
3). The remaining seven developed thyroid
nodules. Although hypofunction occurred
in people who were older when exposed,
none were of the severity observed in the
two who were exposed at 1 year ofage (13).
The proportion with nodules diminished
with age at exposure, and only one person
exposed at over 10 years ofage was affected.
Carcinoma developed in five of24 persons
exposed at 5 to 29 years ofage. In all ofthe
people exposed on Rongelap, 21 of 54
developed these disorders. Figure 4 shows
the difference in the frequency ofnodules
or cancer among those on Rongelap or
Ailingnae under 10 years ofage compared
with thosewho were older at exposure.
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Table3. Thyroid disorders after exposure in 1954 on Rongelap among those who survived at least until 1964.a
Ageb Dose,cGy Number Myxedema Nodules Carcinoma
1 50 9 2 7 0
2 30-40 5 0 3 0
5-9 20-28 6 0 3 1
10-19 11-18 12 0 0 3
20-29 10-11 6 0 1 1
30+ 10 16 0 0 0
Total 54 2 14 5
aFrom Adams et al. (12). bAt exposure. ODue to radioiodines; in addition, each person received 1.9 Gy from exter-
nal radiation.
1.0
0.8
0.0
.0.4
0.2
0 Il
0 5 10 15 20 25 30 35
Years since exposure
Figure 4. Development of thyroid nodules or carci-
noma among Marshallese exposed on Rongelap or
Ailingnae, exposure under age 15 compared with 15+.
Data from Lessard et al. (11). (U), Age <10 at exposure
(n=28); (0), age>10 at exposure (n=54). p<0.001.
Thyroid nodules and carcinoma were
not diagnosed until 10 years after exposure,
which implies a latent period ofthis dura-
tion regardless of age at exposure. This
latent period is the time from exposure to
clinical detection; the latent period
between exposure and thyroid dysfunction
may be shorter (11).
From these data, it is clear that expo-
sure to fallout from a nuclear weapons test
caused effects on the thyroid that were fre-
quent, severe, and age-related. The dose
estimates, based on age, indicate an
increased uptake of iodine by smaller thy-
roid glands, resulting in larger doses among
the young.
Research Needs
There are two main needs. The data from
those exposed to the atomic bombs in
Japan in utero or during childhood have
provided the best data available on carcino-
genic effects from external radiation expo-
sure. This information, over awide spectrum
ofdoses, is the basis for national and inter-
national standards for radiation protection.
The children who were in utero or under
10 years ofage ATB will be 50 to 60 years
old in 1995. Cancer rates mount rapidly
with each passing year. The collection of
incidence data on cancer, far more reliable
than death-certificate data, is about to
reveal the full magnitude and the mecha-
nisms of radiation carcinogenesis in the
most cancer-prone age range. The United
States and Japan provide equal funding for
these studies. Data collection is in peril due
to impending deep U.S. budget cuts.
Influential persons in and out ofgovern-
ment must be enlisted to prevent the col-
lapse ofthese studies.
The second need is for the training ofa
few pediatricians in the late effects ofioniz-
ing radiation. Those who were trained in
about 1950 are reaching the end of their
careers and, with regard to experts on pedi-
atric exposures, there are no replacements
in sight. An intimate knowledge ofpedi-
atric cancer and of radiation effects is
required. The obvious place to look is in
academic pediatrics, possiblypediatric radi-
ology, where a few young physicians might
focus on radiation effects in addition to
their principal interest. The training could
be sponsored by a foundation or govern-
ment agency as it was in 1950.
Conclusions
Ample data are available for studies ofage
differences in radiation effects, based on
external exposures among Japanese atomic-
bomb survivors and high thyroid doses
among Marshallese exposed to fallout. The
increase in cancer occurrence reported
among the in utero-exposed group is still
tentative. As yet, these individuals show no
evidence that their risk ofcancer is greater
than that ofpersons who were older when
exposed. There is, however, clear evidence
that susceptibility to certain cancers is
greater among those with childhood expo-
sure than among those exposed later in life.
Susceptibility to leukemia was greater and
the cell-type distribution was different
among those under 20 years of age than
among persons who were older ATB. The
peak leukemia incidence occurred 5 years
after exposure. Age-related host susceptibil-
ity apparently affects the frequency and
type ofleukemia induced by radiation.
The risk ofbreast cancer also is highest
among those exposed under 20 years of
age. Only a small increase was observed
among those who were exposed at 40+
years ofage. Breast cancer did not develop
among persons exposed as children or ado-
lescents until they reached the usual age for
breast cancer, in contrast to leukemia, for
which the latent period at all ages is simi-
lar. Breast cancer requires aging and is
apparently related to hormone status at
exposure and when the neoplasm develops.
Benign thyroid neoplasia from radio-
iodine fallout on the Marshall Islands was
related to the rate of iodine uptake by the
thyroid, which is greatest early in life.
Thus, age is correlated with dose. The
excessive occurrence ofthyroid carcinoma
among those exposed at 5 to 29 years of
age indicates that something in addition to
dose influences malignant transformation.
Radiation effects have been studied
over a wide range ofage and dose, more so
than other environmental exposures. The
marked influence ofage on the frequency
of radiation effects is related to fetal or
postnatal development. The diversity of
the age relationships indicates that a variety
ofmechanisms is involved.
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